The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 07, 2017
Filed:
Apr. 20, 2012
Applicants:
Michael A. Letavic, San Diego, CA (US);
Dale A. Rudolph, San Diego, CA (US);
Brad M. Savall, San Diego, CA (US);
Brock T. Shireman, San Diego, CA (US);
Devin Swanson, San Diego, CA (US);
Inventors:
Michael A. Letavic, San Diego, CA (US);
Dale A. Rudolph, San Diego, CA (US);
Brad M. Savall, San Diego, CA (US);
Brock T. Shireman, San Diego, CA (US);
Devin Swanson, San Diego, CA (US);
Assignee:
Janssen Pharmaceutica NV, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); C07D 487/04 (2006.01); A61K 31/421 (2006.01); C07D 403/04 (2006.01); C07D 413/10 (2006.01); C07D 403/14 (2006.01); A61K 31/498 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/421 (2013.01); A61K 31/498 (2013.01); A61K 31/506 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 413/10 (2013.01);
Abstract
Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.